Ritonavir Main Page

Medical Advocates
Ritonavir (Norvir)

Main Page

New and Noteworthy
US Pricing
Drug Alerts
Guidelines
Database of ARV Drug Interactions
Journal Data
Conference Data
Perinatal Data
Pediatric Data
Protease Inhibitors: General Data

ARV Drugs Main Page Main New/Newsworthy Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: February 03, 2012
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

January 2012

Ritonavir Interacts With Bortezomib to Enhance Protein Ubiquitination and Histone Acetylation Synergistically
in Renal Cancer Cells
Sato A, Asano T, Ito K, Asano T. Urology. 2012 Jan 30.

Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug
leflunomide in a PPAR-γ-dependent manner.
Mencarelli A, Francisci D, Renga B, et al Antivir Ther. 2012 Jan 25.

Drug Alerts/Updates

NEWS RELEASE
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir (ritonavir) Tablets
Abbott Laboratories Feb 11, 2010

FULL-TEXT DOCUMENT
Norvir (Ritonavir) Soft Gelatin Capsules and Norvir Oral Solution Package Inserts Updated
USFDA Sep 02, 2008

FDA NEWS RELEASE
FDA Approves New Pediatric Dosing Information for Ritonavir
FDA
October 06, 2005
News Release

FDA NEWS RELEASE
Norvir (ritonavir) and Kaletra (lopinavir/ritonavir) package inserts updated to include
information regarding interactions with fluticasone
FDA
March 30, 2005
News Release

BMS DRUG ALERT
Desyrel (trazodone) hydrochloride/ritonavir interaction
May 2004
Letter

ARV Drugs Main Page Main New/Newsworthy Home Page

Ritonavir Main Page